Loading, please wait...
:

product description page

Orphan Drugs : From Regulatory Issues to Clinical Transition (Hardcover)

Orphan Drugs : From Regulatory Issues to Clinical Transition (Hardcover) - image 1 of 1

About this item

While drug discovery for common disorders is somewhat standard and based on the large potential markets, the small market for most orphan diseases means that effective therapies are uncommon. With next generation DNA sequencing, the pace of inherited novel rare disease gene identification has increased markedly. Drug discovery for rare diseases is somewhat hampered by a lack of collaboration between academia and industry separating the necessary resources from skills. This volume discusses important aspects of orphan drug development such as regulatory affairs, public industry partnership, bench to bedside using examples of rare diseases, challenges of clinical trials and future directions.

Number of Pages: 320
Genre: Medical, Science
Series Title: Frontiers in Neurotherapeutics
Format: Hardcover
Publisher: Taylor & Francis
Language: English
Street Date: December 15, 2017
TCIN: 51993153
UPC: 9781498763073
Item Number (DPCI): 248-39-1970
If the item details above aren’t accurate or complete, we want to know about it. Report incorrect product info.
$149.95
Shipping not available
Not in stores

Guest reviews

Prices, promotions, styles and availability may vary by store & online. See our price match guarantee. See how a store is chosen for you.


*See offer details. Restrictions apply. Pricing, promotions and availability may vary by location and at Target.com.